In other countries
The same active substances on other registers, the same brand first.
- Adzenys XR-ODTUnited States · 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … · tablet, orally disintegrating, extended release · Neos TherapsSame substance
- AmphetamineUnited States · 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … · tablet, orally disintegrating, extended release · Actavis Labs FL INCSame substance
- Amphetamine SulfateUnited States · 10MG, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG … · tablet · GranulesSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Amfetamine
- Strength
- 25 MG
- Dosage form
- Capsule (Extended-Release)
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 30 Jan 2004
- Registration
- DIN 02248812
- Marketing authorisation holder
- Takeda Canada INC
- ATC code
- N06BA01
- Group
- Nervous system
- Supply
- CONTROLLED DRUGS (CDSA I)